Glomerular actions of a free radical-generated novel prostaglandin, 8-epi-prostaglandin F2 alpha, in the rat. Evidence for interaction with thromboxane A2 receptors. Takahashi K, Nammour TM, Fukunaga M, Ebert J, Morrow JD, Roberts LJ, Hoover RL, Badr KF (1992) J Clin Invest 90: 136-41 Pulmonary vascular effects of prostaglandin D2, but not its systemic vascular or airway effects, are mediated through thromboxane receptor activation. King LS, Fukushima M, Banerjee M, Kang KH, Newman JH, Biaggioni I (1991) Circ Res 68: 352-8 The mGluR2 positive allosteric modulator BINA decreases cocaine self-administration and cue-induced cocaine-seeking and counteracts cocaine-induced enhancement of brain reward function in rats. Jin X, Semenova S, Yang L, Ardecky R, Sheffler DJ, Dahl R, Conn PJ, Cosford ND, Markou A (2010) Neuropsychopharmacology 35: 2021-36 Thromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesis. Daniel TO, Liu H, Morrow JD, Crews BC, Marnett LJ (1999) Cancer Res 59: 4574-7 RhoB plays an essential role in CXCR2 sorting decisions. Neel NF, Lapierre LA, Goldenring JR, Richmond A (2007) J Cell Sci 120: 1559-71 The lateral mobility of NHE3 on the apical membrane of renal epithelial OK cells is limited by the PDZ domain proteins NHERF1/2, but is dependent on an intact actin cytoskeleton as determined by FRAP. Cha B, Kenworthy A, Murtazina R, Donowitz M (2004) J Cell Sci 117: 3353-65 Mediation of renal vascular effects of epidermal growth factor by arachidonate metabolites. Harris RC, Munger KA, Badr KF, Takahashi K (1990) FASEB J 4: 1654-60 Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages. Wang JW, Woodward DF, Martos JL, Cornell CL, Carling RW, Kingsley PJ, Marnett LJ (2016) FASEB J 30: 394-404 Discovery and Structure-Based Optimization of Potent and Selective WD Repeat Domain 5 (WDR5) Inhibitors Containing a Dihydroisoquinolinone Bicyclic Core. Tian J, Teuscher KB, Aho ER, Alvarado JR, Mills JJ, Meyers KM, Gogliotti RD, Han C, Macdonald JD, Sai J, Shaw JG, Sensintaffar JL, Zhao B, Rietz TA, Thomas LR, Payne WG, Moore WJ, Stott GM, Kondo J, Inoue M, Coffey RJ, Tansey WP, Stauffer SR, Lee T, Fesik SW (2020) J Med Chem 63: 656-675 Mto2p, a novel fission yeast protein required for cytoplasmic microtubule organization and anchoring of the cytokinetic actin ring. Venkatram S, Jennings JL, Link A, Gould KL (2005) Mol Biol Cell 16: 3052-63 A randomized, double-blind, placebo-controlled crossover study of α4β 2* nicotinic acetylcholine receptor agonist AZD1446 (TC-6683) in adults with attention-deficit/hyperactivity disorder. Jucaite A, Öhd J, Potter AS, Jaeger J, Karlsson P, Hannesdottir K, Boström E, Newhouse PA, Paulsson B (2014) Psychopharmacology (Berl) 231: 1251-65 A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity. Galici R, Echemendia NG, Rodriguez AL, Conn PJ (2005) J Pharmacol Exp Ther 315: 1181-7 Pyridoxine-derived bicyclic aminopyridinol antioxidants: synthesis and their antioxidant activities. Nam TG, Ku JM, Rector CL, Choi H, Porter NA, Jeong BS (2011) Org Biomol Chem 9: 8475-82 Intraarterial administration of norcantharidin attenuates ischemic stroke damage in rodents when given at the time of reperfusion: novel uses of endovascular capabilities. Khan IS, Odom M, Ehtesham M, Colvin D, Quarles CC, McLaughlin B, Singer RJ (2016) J Neurosurg 125: 152-9 A pharmacokinetic study on Z-(+/-)-2-(1-benzylindole-3-yl-methylene)azabicyclo[2.2.2]octane-3-ol; a novel radio-sensitization agent. Al-Ghananeem AM, Albayati ZF, Malkawi A, Sonar VN, Freeman ML, Crooks PA (2007) Cancer Chemother Pharmacol 60: 915-9 Isoprostanes as physiological mediators of transition to newborn life: novel mechanisms regulating patency of the term and preterm ductus arteriosus. Chen JX, O'Mara PW, Poole SD, Brown N, Ehinger NJ, Slaughter JC, Paria BC, Aschner JL, Reese J (2012) Pediatr Res 72: 122-8 Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata. Johnson KA, Niswender CM, Conn PJ, Xiang Z (2011) Neurosci Lett 504: 102-106
Hints: (1) double-click or double-tap to navigate to a node. (2) Grab a node and move it to arrange the graph.